Wave Life Sciences (WVE) Retained Earnings (2014 - 2026)
Wave Life Sciences (WVE) posted Retained Earnings of -$254000.0 for Q1 2026, down 100.11% on a QoQ basis from $228.4 million in Q4 2025, and up 99.98% year-over-year from -$127013.8 in Q1 2025.
Wave Life Sciences (WVE) Retained Earnings (2014 - 2026) Analysis & Trends
Wave Life Sciences' Retained Earnings history runs 13 years deep, the most recent figure standing at -$254000.0 for Q1 2026.
- Quarterly Retained Earnings rose 99.98% year-over-year to -$254000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$254000.0 (up 99.98% YoY) and the FY2025 annual result came in at $228.4 million, up 120.36% from the prior year.
- Retained Earnings was -$254000.0 for Q1 2026 at Wave Life Sciences, down from $228.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at $228.4 million in Q4 2025 and bottomed at -$1.2 billion in Q1 2025.
- A 5-year average of -$200.4 million and a median of -$124000.0 in 2023 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 90502.0% in 2024, while the deepest fall reached 904624.19% in 2024.
- Wave Life Sciences' Retained Earnings stood at -$29000.0 in 2022, then slumped by 327.59% to -$124000.0 in 2023, then slumped by 904624.19% to -$1.1 billion in 2024, then jumped by 120.36% to $228.4 million in 2025, then slumped by 100.11% to -$254000.0 in 2026.
- Business Quant data shows WVE's Retained Earnings at -$254000.0 in Q1 2026, $228.4 million in Q4 2025, and $174.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | -254,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -254,000.00 |
| Dec 31, 2025 | 228.37 Mn |
| Sep 30, 2025 | 174.08 Mn |
| Jun 30, 2025 | 167.60 Mn |
| Mar 31, 2025 | -1.17 Bn |
| Dec 31, 2024 | -1.12 Bn |
| Sep 30, 2024 | -1.15 Bn |
| Jun 30, 2024 | 135.60 Mn |
| Mar 31, 2024 | -198,000.00 |
| Dec 31, 2023 | -124,000.00 |
| Sep 30, 2023 | -182,000.00 |
| Jun 30, 2023 | -150,000.00 |
| Mar 31, 2023 | 122.19 Mn |
| Dec 31, 2022 | -29,000.00 |
| Sep 30, 2022 | -123,000.00 |
| Jun 30, 2022 | -884.62 Mn |
| Mar 31, 2022 | 91.95 Mn |
| Dec 31, 2021 | 181,000.00 |
| Sep 30, 2021 | 84.25 Mn |
| Jun 30, 2021 | -764.50 Mn |